ARCHIVES

Adverse Events Of Chemo More Common Than Expected

This article is from The Cancer Letter archive.

Vol. 29 No. 8 | August 25, 2006

Download PDF Visit The Full Archive

Related Articles

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

Obama Signs Spending Bill for FY09

March 13, 2009

Funding opportunities listed.

September 17, 2004

Panel Tells Carter Cancer Program Needs More Money

March 4, 1977

Heart Function Of Breast Cancer Patients Should Be Monitored, Two Studies Find

August 25, 2006